Cargando…
The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?
The world of human immunodeficiency virus (HIV) vaccines has suffered a baffling setback. The first trial of a vaccine designed to elicit strong cellular immunity has shown no protection against infection. More alarmingly, the vaccine appeared to increase the rate of HIV infection in individuals wit...
Autor principal: | Sekaly, Rafick-Pierre |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2234358/ https://www.ncbi.nlm.nih.gov/pubmed/18195078 http://dx.doi.org/10.1084/jem.20072681 |
Ejemplares similares
-
The aftermath of the Merck's HIV vaccine trial
por: Iaccino, Enrico, et al.
Publicado: (2008) -
Networks of innovation: vaccine development at Merck, Sharp & Dohme, and Mulford, 1895–1995
por: Stanton, Jennifer
Publicado: (1997) -
Launching COVID-19 vaccination in Saudi Arabia: Lessons learned, and the way forward
por: Assiri, Abdullah, et al.
Publicado: (2021) -
Commentary: Back to the future: Failed mitral valve bioprosthesis in the setting of mitral annular calcification
por: Parchment, Nathaniel, et al.
Publicado: (2021) -
A systems framework for vaccine design
por: Mooney, Michael, et al.
Publicado: (2013)